Silverarc Capital Management, LLC Cti Biopharma Corp Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $3.24 Million - $4.5 Million	-729,155 Reduced 74.14%	254,361 $1.53 Million
Q3 2022 Oct 28, 2022	SELL	$5.36 - $7.43 $2.13 Million - $2.95 Million	-396,595 Reduced 28.74%	983,516 $5.72 Million
Q2 2022 Jul 25, 2022	SELL	$3.55 - $6.27 $3.09 Million - $5.45 Million	-869,889 Reduced 38.66%	1,380,111 $8.24 Million
Q1 2022 May 13, 2022	BUY	$1.9 - $5.23 $1.46 Million - $4.01 Million	766,171 Added 51.63%	2,250,000 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $2.14 Million - $4.24 Million	1,483,829 New	1,483,829 $3.68 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.